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Introduction {#sec1}
============

Normal tissues progressively accumulate cells carrying somatic mutations, some of which are linked to neoplasia and other diseases ([@bib15], [@bib26], [@bib36], [@bib38], [@bib42]). This process is exemplified by human esophageal epithelium (EE), in which mutations generated by cell-intrinsic processes colonize the majority of normal epithelium by middle age ([@bib27], [@bib39]). The most common mutations are under strong positive selection, meaning that there is an excess of protein altering over silent mutations within each gene. This indicates that these mutations confer a competitive advantage over wild-type cells and drive clonal expansions in normal tissue ([@bib3], [@bib2], [@bib17], [@bib30]).

We speculated that, as in other systems of competitive selection, altering the tissue environment may change the relative fitness of particular mutations and their prevalence in the tissue. In this study, we focused on *p53* (human *TP53*, mouse *Trp53*) mutations because these are the most enriched during malignant transformation. *p53* is mutated in 5%--10% of normal EE but in almost all esophageal squamous cell carcinomas (ESCCs) ([@bib27], [@bib8]). This argues that ESCC emerges from the *p53* mutant cell population in normal epithelium and that mutation of *p53* is required for cancer development.

To investigate the effect of environment on mutational selection, we used mouse EE as a model tissue. This consists of layers of keratinocytes. Proliferation is confined to the lowest, basal cell layer, whereas the upper cell layers contain non-dividing cells that progressively differentiate as they migrate toward the tissue surface, where they are shed ([@bib3], [@bib13], [@bib14]; [Figure 1](#fig1){ref-type="fig"}A). Although apoptosis is negligible in normal epithelium, cells are continually lost by shedding throughout life, creating a requirement for continuous cell production in the basal layer to maintain cellular homeostasis. This is achieved by a single population of progenitor cells that divide to generate either two progenitor daughters that remain in the basal layer, two differentiated daughters that exit the basal layer, or one cell of each type ([@bib13], [@bib25]). The outcome of an individual progenitor division is unpredictable, but the probabilities of each outcome are balanced so that, across the population of progenitors, the average cell division generates equal proportions of progenitor and differentiated cells, maintaining cellular homeostasis ([Figure 1](#fig1){ref-type="fig"}A).Figure 1Cell Behavior in Mouse Esophageal Epithelium(A) Cartoon showing the mouse esophageal epithelium structure. Progenitor cells in the basal layer divide to generate progenitor and differentiating daughter cells. The latter subsequently exit the cell cycle and migrate out of the basal layer through the suprabasal cell layers to the epithelial surface from which they are shed. Progenitor division may generate two progenitors, two differentiated cells, or one of each cell type. The probabilities of each symmetric division outcome (indicated by percentages) are balanced so that, on average, across the basal layer, each division generates 50% progenitors and 50% differentiating cells.(B) Clonal dynamics. The behavior of progenitors results in most cells that acquire a neutral mutation being lost by differentiation and shedding within a few rounds of division (left clone). Only a few clones will expand to a size that means they are likely to persist long term (right clone).(C) Positively selected mutants tilt the normally balanced average division outcome toward proliferation, increasing the proportion of persisting mutant clones, whereas a negatively selected mutation that tilts fate toward differentiation will be depleted from the tissue because an increased proportion of clones will be lost by shedding.

These insights into normal progenitor cell behavior are key to understanding the dynamics of mutant clones and their selection. Clones carrying neutral mutations that do not alter cell behavior are likely to be lost from the tissue within a few rounds of cell division because, if all progenitor cells divide to produce two differentiated cells, the clone will be lost from the tissue by shedding ([Figure 1](#fig1){ref-type="fig"}B). By chance, however, a few neutral mutant clones will expand to a size where the differentiation of all cycling cells within them is unlikely, enabling them to persist in the epithelium ([Figure 1](#fig1){ref-type="fig"}B; [@bib13]). Such neutral behavior contrasts with clones harboring positively selected mutations that give the mutant cells a competitive advantage because of the average mutant progenitor division generating more progenitor than differentiated cells ([Figure 1](#fig1){ref-type="fig"}C; [@bib3], [@bib14], [@bib30]). This results in an increased proportion of persistent clones than is seen with neutral mutations ([Figure 1](#fig1){ref-type="fig"}C). Furthermore, because there is no restriction of the lateral spread of clones within the basal layer, such clones may expand over a large area ([@bib3], [@bib13]). Conversely, mutations that tilt the average division outcome toward differentiation have an increased likelihood of loss by shedding and will be outcompeted by wild-type cells.

Insight into normal and mutant cell behavior in EE has come from genetic lineage tracing studies in transgenic mice ([Figure S1](#mmc1){ref-type="supplementary-material"}; [@bib3], [@bib1], [@bib13], [@bib14]). Here we apply this technique to test whether the selection of *p53* mutant clones is altered by oxidative stress resulting from low-dose ionizing radiation (LDIR) with doses similar to those from medical imaging and environmental contamination ([@bib11], [@bib19]). We find that LDIR exposure promotes the expansion of *p53* mutant clones. However, when LDIR is combined with antioxidant treatment, wild-type cell fitness exceeds that of the *p53* mutants, which are depleted from the tissue.

Results {#sec2}
=======

LDIR Drives Wild-Type Progenitor Differentiation in EE {#sec2.1}
------------------------------------------------------

We began by determining the effects of a range of whole-body ionizing radiation (IR) doses on EE in wild-type mice. IR exposure led to a dose-dependent increase in double-strand breaks (DSBs) and a decrease in proliferation 24 h after exposure ([Figures S2](#mmc1){ref-type="supplementary-material"}A--S2J). We selected 50 mGy, equivalent to 3--4 computed tomography (CT) scans, for further study ([@bib11]). This dose resulted in an average of one DSB in every 5 cells and did not change proliferation marker expression 24 h after irradiation or induce apoptosis ([Figures S2](#mmc1){ref-type="supplementary-material"}C, S2D, S2G--S2J, and S2K--S2M).

To track the behavior of esophageal progenitor cells, we used a highly sensitive genetic lineage tracing assay. Yellow fluorescent protein (YFP) expression was induced by genetic recombination in individual progenitor cells in *Ahcre*^*ERT*^*Rosa26*^*flEYFP/WT*^ (*RYFP*) transgenic mice ([Figures 2](#fig2){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}A). YFP expression was inherited by the progeny of the labeled cell, forming a clone. Analysis of the number and location of cells in multiple clones reveals cell behavior ([@bib1], [@bib10], [@bib13]; [Figures 2](#fig2){ref-type="fig"}A and 2B). A week after YFP induction, mice were exposed to 50 mGy IR, after which clone sizes were measured by 3D confocal imaging ([Figure 2](#fig2){ref-type="fig"}C). 24 h after LDIR, YFP-expressing clones contained a significantly higher proportion of differentiated, suprabasal cells and "floating" clones lacking basal cells destined to be shed than those in non-irradiated animals ([Figures 2](#fig2){ref-type="fig"}D and 2E). Basal cell density (cells per area) was reduced, but no radiation-induced apoptosis was detected ([Figures 2](#fig2){ref-type="fig"}F and [S2](#mmc1){ref-type="supplementary-material"}K--S2M). These changes were consistent with progenitor cells differentiating and leaving the basal layer over the 24 h after irradiation ([Figures 2](#fig2){ref-type="fig"}F, [S2](#mmc1){ref-type="supplementary-material"}E, S2F, S2K--S2M, [S3](#mmc2){ref-type="supplementary-material"}K, and S3L). By 48 h after exposure, the proportion of proliferating basal cells and the size of clones rose ([Figures S3](#mmc1){ref-type="supplementary-material"}H and [2](#fig2){ref-type="fig"}D). These results argue that LDIR induces basal cell differentiation followed by increased compensatory proliferation.Figure 2LDIR Promotes Keratinocyte Progenitor Differentiation *In Vivo*(A) Experimental protocol: *cre* was induced 7 days before irradiation in yellow fluorescent protein (YFP) reporter mice (RYFP, yellow arrow). Samples were collected 24 and 48 h after irradiation.(B) Lineage cell tracing in EE. YFP is induced in single progenitor cells in the basal cell layer, which generate YFP-expressing clones.(C) Rendered confocal z stacks showing side views of a typical basal clone containing one or more basal cells (top panel) and a floating clone with no basal cells (bottom). Arrowheads indicate basal cells (red) and suprabasal cells (white). Dashed lines indicate the basement membrane. Scale bars, 10 μm.(D) Heatmaps representing the frequency of clone sizes with the number of basal and supra-basal cells indicated (left panels) and differences between 0 and 50 mGy irradiated animals (right panels) at 24 and 48 h. Black dots and dashed lines indicate the geometric median clone size. Average total clone size is indicated within each plot. ^∗∗∗∗^p = 6 × 10^−8^ and 5 × 10^−48^ at 24 and 48 h, respectively (Peacock's test). n = 1000 clones per condition at 24 h and 1,530 (0 mGy) and 1,800 (50 mGy) clones at 48 h.(E and F) Percentage of floating to total clones (E) and basal cell density (F) 24 and 48 h after irradiation. Each dot is the mean value from one mouse. ^∗∗∗∗^p \< 0.0001, ^∗∗∗^p \< 0.001, and ^∗∗^p \< 0.01 (unpaired t test). In (F), at least 12,000 basal cells were analyzed per condition.(G) Summary. After LDIR, basal cell density decreases, and numerous floating clones appear as cells migrate out of the basal layer. Proliferation then increases, and by 10 days, the epithelium is restored to normal.(H) Primary EE culture protocol. EE generated from explants was treated with a 1-h pulse of EdU (red arrow) exposed to LDIR and analyzed 24 h later.(I) Rendered confocal z stacks of typical cultures 24 h after 0 or 50 mGy LDIR. Differentiated suprabasal keratinocytes stain for KRT4 (red), wheat germ agglutinin (white), and DAPI (blue). Scale bars, 25 μm.(J) and (K) *In vitro* EdU lineage tracing. Shown are the percentage of EdU^+^ suprabasal cells (J) and percentage of EdU^+^ total cells (K) after 0 or 50 mGy LDIR. Each point represents the mean from a biological replicate culture from a different mouse. ^∗∗^p \< 0.01, ^∗^p \< 0.05 (unpaired t test); n = 6; total EdU^+^ cells, 1,291 (0 mGy), 4,256 (50 mGy).See also [Figures S1--S4](#mmc1){ref-type="supplementary-material"} and [Tables S2](#mmc1){ref-type="supplementary-material"} and [S4](#mmc3){ref-type="supplementary-material"}.

In parallel with genetic lineage tracing, we also performed short-term lineage tracing using ethinyl deoxyuridine (EdU) in animals exposed to LDIR ([@bib14], [@bib25]). A pulse of EdU was used to label the DNA of progenitors in S phase of the cell cycle, allowing us to examine the behavior of a synchronized cohort of proliferating cells. EdU is passed on to the progeny of the labeled cells when they divide, allowing pairs of labeled cells from each division to be visualized by confocal imaging of EE ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B). 24 h after 50 mGy irradiation, the proportion of differentiated EdU-labeled cells was significantly increased compared with controls ([Figure S3](#mmc1){ref-type="supplementary-material"}C). There was no change in the total number of EdU cells, indicating no increase in cell division ([Figure S3](#mmc1){ref-type="supplementary-material"}D). The density of cells in the basal layer was reduced in irradiated mice and consistent with an increase in suprabasal cell density unmatched by an increase in proliferation ([Figures S3](#mmc1){ref-type="supplementary-material"}E and S3F). By 48 h after exposure, the total number of EdU^+^ cells was higher in irradiated mice than in control mice, indicating an increase in cell division compensating for basal cell differentiation.

Consistent with a delayed onset of proliferation, measuring the proportion of basal cells in S phase by giving mice EdU 1 h before culling revealed an increase in S phase cells 48 h after irradiation ([Figures S3](#mmc1){ref-type="supplementary-material"}G and S3H). By 10 days, EE in irradiated mice had returned to homeostasis, with a similar proportion of S phase basal cells and basal cell density as control animals ([Figure S3](#mmc1){ref-type="supplementary-material"}I). We concluded that both genetic and EdU lineage tracing indicate that LDIR alters cell dynamics in EE, inducing a wave of basal cell differentiation followed by increased proliferation that restores the tissue to homeostasis ([Figure 2](#fig2){ref-type="fig"}G). A similar delay in cell division following differentiation of nearby cells has also been observed in the epidermis ([@bib28]).

We then assessed whether the induction of differentiation was a direct effect of LDIR on EE cells or an indirect consequence of irradiating another cell type. To this end, we established primary 3D keratinocyte cultures from explants of murine EE and exposed them to 0 or 50 mGy LDIR ([Figure 2](#fig2){ref-type="fig"}H). We observed a substantial increase in the proportion of suprabasal cells expressing the differentiation marker KRT4 24 h after irradiation ([Figure 2](#fig2){ref-type="fig"}I). There was no detectable radiation-induced apoptosis ([Figures S4](#mmc1){ref-type="supplementary-material"}A--S4C). EdU lineage tracing results showed increased differentiation and proliferation paralleling the changes 48 h after LDIR exposure *in vivo* ([Figures 2](#fig2){ref-type="fig"}J and 2K). This confirms that LDIR acts directly on esophageal keratinocytes to induce differentiation.

Mitochondrial Redox Balance Is Altered after 50 mGy of LDIR in Primary Mouse Keratinocytes {#sec2.2}
------------------------------------------------------------------------------------------

Next we investigated the mechanisms by which LDIR acts on esophageal basal cells using primary 3D keratinocyte cultures. One possibility is activation of the cellular DNA damage response (DDR), which has been shown to promote differentiation in some cell lineages ([@bib33]). However, despite LDIR generating a number of DSBs similar to that seen *in vivo*, we found no detectable induction of the DNA DDR pathway, as assessed by levels of phosphorylated p53, CHK1, and CHK2 proteins after 50 mGy irradiation ([Figures S4](#mmc1){ref-type="supplementary-material"}D--S4F). In contrast, a 2-Gy dose had a robust effect on DDR protein phosphorylation ([Figure S4](#mmc1){ref-type="supplementary-material"}F). This reveals that LDIR is unlikely to act via the DDR pathway.

An alternative mechanism of inducing differentiation is LDIR-induced oxidative stress because ionizing radiation can result in a prolonged increase in the production of reactive oxygen species by mitochondria ([@bib5], [@bib32]). Mitochondria are also key players in the regulation of keratinocyte differentiation ([@bib6], [@bib18], [@bib29], [@bib37]). We speculated that LDIR may act by dysregulating the mitochondrial redox state in esophageal cells. To test this, we introduced a mitochondrially targeted redox-sensitive fluorescent sensor, Mito-Grx1-roGFP, into primary EE cultures ([@bib16]; [Figures 3](#fig3){ref-type="fig"}A and 3B). The fluorescence characteristics of the sensor changed after exposing the cells to LDIR, indicating increased mitochondrial oxidation ([Figures 3](#fig3){ref-type="fig"}C and 3D). These changes were abolished by treating cells with the reducing agent DTT, confirming that they were linked to the mitochondrial oxidation state ([Figure 3](#fig3){ref-type="fig"}E). We also treated cells with the oxidant hydrogen peroxide (H~2~O~2~), finding that a dose that induces similar levels of mitochondrial oxidation as 50 mGy irradiation also drives basal cell differentiation, as assessed by staining for the differentiation marker KRT4 and lineage tracing with EdU ([Figures 3](#fig3){ref-type="fig"}F--3I).Figure 3The Mitochondrial Redox Balance Is Significantly Altered after 50 mGy of LDIR in Primary Mouse Keratinocytes(A) Experimental protocol. Primary 3D cultures of EE were infected with an adenovirus encoding a genetic sensor of the mitochondrial redox state, irradiated, and imaged.(B) The Mito-Grx1-roGFP2 reporter is localized to mitochondria. The reduced and oxidized states of the probe are differentially excited by 405 nm and 488 nm light, so the ratio of fluorescence after excitation at the two wavelengths indicates the redox state ([@bib16]).(C) Representative rendered confocal z stacks showing 405 nm/488 nm emission ratios from mitochondria in Mito-Grx1-roGFP2-expressing keratinocytes 60 min after 0 or 50 mGy LDIR, indicated by the pseudo-color scale. Scale bars, 20 μm. Negative (DTT-treated) and positive (H~2~O~2~-treated) controls for oxidation are shown as well. Scale bars, 15 μm.(D) Violin plots of the distribution of 405/488 ratios for individual mitochondria in Mito-Grx1-roGFP2 reporter-expressing keratinocytes 5, 30, and 60 min after LDIR, obtained by quantitative confocal 3D imaging. Controls are oxidized (hydrogen peroxide \[H~2~O~2~\]-treated) and reduced (DTT-treated) cells ^∗∗∗∗^p \< 0.0001, ^∗∗∗^p \< 0.001 (Mann-Whitney *U* test). n is the number of mitochondria imaged under each condition, shown in [Table S2](#mmc1){ref-type="supplementary-material"}. Three biological replicate experiments were performed; results from a representative experiment are shown.(E) Violin plots showing the effect of DTT treatment on irradiated cells. ^∗∗∗∗^p \< 0.0001, ^∗∗∗^p \< 0.001 (Mann-Whitney *U* test).(F--I) Experimental protocol.(F) Primary 3D cultures of EE were labeled with EdU for 1 h and treated with H~2~O~2~ 24 h before immunostaining.(G) Rendered confocal z stacks of typical cultures 24 h after treatment with the control (Ctrl) or 100 μM H~2~O~2~. Differentiated suprabasal keratinocytes were stained for KRT4 (red) and DAPI (blue). Dashed lines indicate the insert's membrane. Scale bars, 20 μm.(H and I) *In vitro* EdU lineage tracing. Shown are the percentage of EdU^+^ suprabasal cells (H) and percentage of EdU^+^ total cells (I) after treatment with the Ctrl or 100 μM H~2~O~2~. Each point represents the mean from a biological replicate culture from a different mouse. ^∗∗^p \< 0.01 (unpaired t test), n = 3; total EdU^+^ cells, 2,435 (Ctrl) and 3,256 (H~2~O~2~).(J--L) Transcriptional profile of irradiated EE cultures from wild-type *C57BL/6J* and *Nrf2*^*−/−*^ mice.(J) Experimental protocol. RNA-seq was performed on biological triplicate cultures 1 and 24 h after 0 or 50 mGy of LDIR.(K and L) MA plots of RNA-seq data of cultures from *C57BL/6J* (K) and *Nrf2*^*−/−*^ mice (L) comparing irradiated and unirradiated cultures at the times shown; red indicates differentially expressed transcripts with adjusted p \< 0.05.(M and N) Rendered confocal z stacks of *C57BL/6J* (M) and *Nrf2*^*−/−*^ (N) cultures 24 h after 0 or 50 mGy LDIR. Differentiated suprabasal keratinocytes were stained for KRT4 (red) and DAPI (blue). Scale bars, 25 μm.See also [Figure S4](#mmc1){ref-type="supplementary-material"} and [Tables S1](#mmc1){ref-type="supplementary-material"} and [S4](#mmc3){ref-type="supplementary-material"}.

The above findings are consistent with LDIR driving differentiation via changes in mitochondrial oxidation. If this is the case, then we might expect cells in which the responses to oxidative stress are disabled because of the lack of the master regulator of the cellular oxidative stress response, the transcription factor *Nrf2* (*Nfe2l2*), to be insensitive to LDIR. We analyzed cultures of wild-type EE using RNA sequencing, finding strong induction of transcripts linked to keratinocyte differentiation within 1 h of exposure to 50 mGy, which became more pronounced 24 h after irradiation ([Figures 3](#fig3){ref-type="fig"}J, [S4](#mmc1){ref-type="supplementary-material"}G, and S4H). However, in cultures of EE from *Nrf2*^*−/−*^ mice, there were no statistically significant changes in transcription following 50 mGy irradiation ([Figures 3](#fig3){ref-type="fig"}L and S4I). This suggests that an intact cellular oxidative stress response pathway is required for LDIR-induced differentiation.

Antioxidant Treatment Abolishes NRF2 Nuclear Translocation and Radiation-Induced Differentiation *In Vivo* {#sec2.3}
----------------------------------------------------------------------------------------------------------

Motivated by our observations in cultures, we set out to test whether LDIR acted via oxidative stress *in vivo*. We began by immunostaining EE from irradiated and control mice for phospho-serine40 NRF2 protein, which accumulates in the nucleus of cells following an oxidative challenge ([@bib20], [@bib21]). We found nuclear staining in basal layer cells 24 h after LDIR exposure, consistent with increased oxidative stress ([Figures 4](#fig4){ref-type="fig"}A and 4B). Next we investigated whether treating mice with the antioxidant N-acetyl cysteine (NAC) would alter the effect of LDIR on EE. NAC treatment at a dose that blocked the accumulation of nuclear NRF2 prevented radiation-induced differentiation of basal cells following 50 mGy IR ([Figures 4](#fig4){ref-type="fig"}C--4I).Figure 4Antioxidant Treatment Abolishes NRF2 Nuclear Translocation and Radiation-Induced Differentiation *In Vivo*(A) Experimental protocol. YFP reporter mice were exposed to 0 or 50 mGy of LDIR with or without NAC treatment, and EE samples were taken 24 h later.(B) NRF2 (phospho-serine40) staining (red) in optimal cutting temperature compound (OCT)-embedded, 10-μm-thick cryosections of EE of *Cyp1A1cre*^*ERT*^*Rosa26*^*flEYFP/WT*^ from (A). Arrowheads show basal cell nuclei positive for NRF2. Also shown are the basement membrane marker ITGA6 (white) and DAPI (blue). Scale bars, 14 μm.(C) Quantification of pSer40 NRF2^+^ basal cells shown in (B). Points are mean values from individual mice. ^∗∗∗∗^p \< 0.0001; n.s., not significant (unpaired t test); n = 4 mice.(D) Experimental protocol. YFP reporter mice were given the oral antioxidant N-acetyl cysteine (NAC) 7 days after cell labeling with YFP (yellow arrow) and throughout the experiment, and EdU was injected 1 h prior to LDIR (red arrow). Clone sizes were analyzed 24 and 48 h after irradiation.(E) Heatmaps showing the frequency of clones containing a number of basal and suprabasal cells observed in 50 mGy versus 0 mGy irradiated animals under NAC treatment. Black dots and dashed lines show geometric median clone size.(F) Frequency of changes observed in 50 mGy NAC-treated versus 50 mGy non-treated animals. ^∗∗∗∗^p \< 0.0001 (Peacock's test), n = 600 clones per condition.(G**--**I) Percentage of floating clones (G), percentage of EdU^+^ suprabasal cells (H), and basal cell density (I) 24 h and 48 h after 0 or 50 mGy LDIR. Points are mean values from individual mice. n.s., p \> 0.05 by unpaired t test; n = 4 mice per condition.See also [Tables S2](#mmc1){ref-type="supplementary-material"} and [S4](#mmc3){ref-type="supplementary-material"}.

The *p53*^*∗/WT*^ Mutant Population Expands after Single Exposure or Multiple Exposures to LDIR {#sec2.4}
-----------------------------------------------------------------------------------------------

Having established that LDIR alters wild-type cell dynamics in EE, we set out to see whether it might influence the selection of cells carrying mutations that drive clonal expansion in the human esophagus. We focused on *p53* as a key a regulator of cellular responses to oxidative and other stresses that is commonly mutated in normal human EE and is almost ubiquitous in ESCC ([@bib27]). In addition, both humans and mice with germline heterozygous *p53* mutations are at an increased risk of developing esophageal tumors ([@bib22], [@bib34]). We first investigated the effect of LDIR on *p53* mutant clones in EE using lineage tracing in *Ahcre*^*ERT*^*p53*^*flR245W-GFPWT*^ transgenic mice, hereafter called *p53*^*∗/WT*^ ([@bib30]). In these animals, *cre*-mediated inducible genetic recombination results in heterozygous expression of the mouse equivalent of the human *TP53*^*R248W*^ mutant in scattered single cells ([Figures S1](#mmc1){ref-type="supplementary-material"}B and S1C). This *p53* mutant has properties distinct from a null allele and is frequently found in keratinocyte-derived cancers ([@bib35], [@bib41]). In induced *p53*^*∗/WT*^ mice, *p53^∗^*-expressing cells can be tracked because they express a GFP reporter. One week after *p53^∗^* induction, animals were exposed to 50 mGy IR ([Figures 5](#fig5){ref-type="fig"}A and 5B). We found that *p53*^*∗/WT*^ clones were significantly larger and had fewer differentiated and more basal cells than both unirradiated *p53*^*∗/WT*^ mice and *p53*^*WT/WT*^ clones in *RYFP* control animals. ([Figures 5](#fig5){ref-type="fig"}C and 5D). These changes were more marked after a course of five 50-mGy exposures over 30 days; the size of *p53*^*∗/WT*^ clones increased substantially, and there was 4-fold increase in the population of p53 mutant basal cells in the epithelium ([Figures 5](#fig5){ref-type="fig"}E--5G). The enlarged clones again contained a higher proportion of basal cells than unirradiated controls, pointing to a persistent radiation-induced bias in cell fate from differentiation toward proliferation ([Figure 5](#fig5){ref-type="fig"}H). To test this hypothesis, we performed short-term EdU lineage tracing of cells in which a pulse of EdU was delivered prior to the final radiation exposure, allowing the behavior of mutant progenitors to be compared with adjacent unrecombined *p53* wild-type cells in the same animal ([Figure 5](#fig5){ref-type="fig"}E). This revealed that cycling p53 mutant progenitors were less likely to differentiate than their wild-type equivalents ([Figure 5](#fig5){ref-type="fig"}I). We also compared the effects of a series of ten exposures of 50 mGy LDIR with a single 500-mGy dose. Repeated low doses resulted in a dramatic increase in *p53*^*∗/WT*^ clone size compared with the single large dose, indicating that the same total dose is more effective at expanding the *p53*^*∗/WT*^ population when given as multiple small exposures ([Figures 5](#fig5){ref-type="fig"}J--5L). This reveals that a single exposure or multiple LDIR exposures act as positive selective pressure for *p53*^*∗/WT*^ cells in normal EE, based on the resistance of mutant cells to radiation-induced differentiation.Figure 5The *p53*^*∗/WT*^ Mutant Population Expands after Single Exposure or Multiple Exposures to LDIR(A) Experimental protocol. Mice with a conditional *p53*^*R245W-GFP/WT*^ (*p53*^*∗/WT*^) allele were induced (green arrow), giving p53^∗^ and GFP expression in single progenitor cells. 7 days later, animals were irradiated with a single exposure of 50 mGy of LDIR and culled 48 h after the last irradiation.(B) Cartoon of lineage tracing in this protocol.(C) Heatmaps showing the frequency of *p53*^*∗/WT*^ clones containing the number of basal and suprabasal cells indicated (left panels) and the frequency change observed when comparing 0 and 50 mGy irradiated animals (right panel). Black dots, geometric clone-size median. ^∗∗∗^p = 0.0007 (Peacock's test); n = 150 and 450, respectively.(D) Heatmaps showing the frequency change observed when comparing *p53*^*∗/WT*^ and *p53*^*WT/WT*^ (wild-type) clones 48 h after exposure to 0 or 50 mGy LDIR. ^∗∗∗∗^p \< 0.0001 (Peacock's test).(E) Experimental protocol. Mice with a conditional *p53*^*R245W-GFP/WT*^ (*p53*^*∗/WT*^) allele were induced (green arrow), giving p53^∗^ and GFP expression in single progenitor cells. 7 days later, animals were irradiated with five doses of 50 mGy of LDIR over 30 days, commenced with a minimal separation of 3 days between each dose. EdU was given 1 h prior to the last irradiation (red arrow), and animals were culled 48 h later.(F) Top-down views of confocal z stacks of typical EE whole mounts showing *p53*^∗/*WT*^ clones (green) after 0 or 50 mGy × 5 LDIR. Basal layer cells are shown (DAPI, blue). Scale bars, 28 μm.(G) Percentage of *p53*^*∗/WT*^ basal cells after 0 or 50 mGy × 5. Points show mean values from individual mice. ^∗∗∗^p \< 0.001 (t test); n = 7 (0 mGy) and n = 6 (50 mGy) mice.(H) Heatmaps showing the frequency of *p53*^*∗/WT*^ clones containing the number of basal and suprabasal cells of the indicated sizes (left panels) and the frequency change observed in 0 and 50 mGy × 5 doses irradiated animals (right panel). Black dots and dashed lines indicate geometric median clone size. ^∗∗∗∗^p \< 0.0001 (Peacock's test), n = 300 clones per condition.(I) Comparison of *p53*^*∗/WT*^ clones with adjacent *p53*^*WT/WT*^ EE in the same irradiated animal. Shown is the percentage of EdU^+^ suprabasal cells. Points show mean values from 3 mice, and lines link the same animal. ^∗^p \< 0.05 (paired t test).(J) Experimental protocol to study repeated radiation exposure. *p53*^*R245W-GFP/WT*^ mice were induced as in (A) and (E), and 7 days later, animals were irradiated with a single dose of 500 mGy or with a course of ten doses of 50 mGy. At 30 days, both groups were analyzed for *p53*^*∗/WT*^ clone size.(K) Top-down views of confocal z stacks of typical EE whole mounts showing *p53*^∗/*WT*^ clones (green) 1 month after 500 mGy or 50 mGy × 10 LDIR. Basal layer cells are shown (DAPI, blue). Scale bars, 30 μm.(L) Percentage of *p53*^*∗/WT*^ basal cells shown in (K). ^∗∗∗∗^p \< 0.0001 (t test). At least 25,000 basal cells were quantified per condition. n = 4 mice per condition.(M) and (N) Primary keratinocyte 3D cultures from *p53*^*WT/WT*^ and *p53*^*∗/WT*^ EE were infected with an adenovirus encoding a genetic sensor of the mitochondrial redox state and irradiated, and single mitochondria were imaged by confocal microscopy. Violin plots show the distribution of 405/488 ratios for individual mitochondria in Mito-Grx1-roGFP2 reporter-expressing keratinocytes from *p53*^*WT/WT*^ (white in M; orange in N) and *p53*^*∗/WT*^ (green) 5, 30, and 60 min after 0 mGy (M) or 50 mGy LDIR (N), obtained by quantitative confocal 3D imaging. Controls are oxidized (H~2~O~2~-treated) and reduced (DTT-treated) cells for each strain. ^∗∗∗∗^p \< 0.0001 (Mann-Whitney *U* test). The numbers of mitochondria imaged under each condition are shown in [Table S1](#mmc1){ref-type="supplementary-material"}. Three biological replicate experiments were performed; results from a representative experiment are shown.See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S5](#mmc1){ref-type="supplementary-material"} and [Tables S2](#mmc1){ref-type="supplementary-material"} and [S4](#mmc3){ref-type="supplementary-material"}.

The *p53*^*∗/WT*^ Mutant Population Is Resistant to Radiation-Induced Differentiation {#sec2.5}
-------------------------------------------------------------------------------------

We next investigated the basis of the competitive advantage of *p53*^*∗/WT*^ over wild-type cells following LDIR, speculating that the mutant cells may be resistant to the radiation-induced alteration in mitochondrial redox state seen in wild-type cells. In keeping with this hypothesis, primary cultures of *p53*^*∗/WT*^ EE exhibited lower baseline levels of mitochondrial oxidation than wild-type cells ([Figure 5](#fig5){ref-type="fig"}M), and these were little changed in the mutant following exposure to 50 mGy LDIR ([Figure 5](#fig5){ref-type="fig"}N). This suggested that *p53*^*∗/WT*^ may express higher levels of cellular antioxidants, protecting them from the effects of LDIR in a manner similar to NAC treatment of wild-type cells. In keeping with this hypothesis, RNA sequencing (RNA-seq) analysis of mutant cultures revealed minimal change in the global transcriptome or transcription following LDIR ([Figures S5](#mmc1){ref-type="supplementary-material"}A and S5B). We noted that transcription of the *p53^∗^* allele was unaltered by LDIR and that, in contrast to wild-type cells, differentiation associated transcripts were not upregulated by irradiation of mutant cultures ([Figures S5](#mmc1){ref-type="supplementary-material"}C--S5E). Both unirradiated and LDIR-treated *p53*^*∗/WT*^ cells showed substantially higher levels of transcripts encoding oxidative stress response genes compared with *p53*^*WT/WT*^ cells ([Figure S5](#mmc1){ref-type="supplementary-material"}F).

To further test whether the competitive advantage of *p53*^*∗/WT*^ over wild-type cells was mediated by differences in their response to oxidative stress, we examined mixed cultures containing both *p53* wild-type and mutant cells ([Figure S6](#mmc1){ref-type="supplementary-material"}A). Treatment with LDIR or H~2~O~2~ resulted in expansion of the mutant population at the expense of wild-type cells ([Figures S6](#mmc1){ref-type="supplementary-material"}B and S6C). The competitive advantage of the p53 mutant cells was abolished by exposing the cultures to NAC.

The *p53*^*∗/WT*^ Mutant Population Decreases after Combined Antioxidant Treatment and Several LDIR Exposures {#sec2.6}
-------------------------------------------------------------------------------------------------------------

Taken together, the findings above led us to conclude that the heightened resilience of p53 mutant cells to oxidative stress explains their selection over wild-type cells in EE exposed to LDIR. This motivated us to test whether NAC treatment could also block LDIR-driven mutant clone expansion *in vivo* in *p53*^*∗/WT*^ mice ([Figure 6](#fig6){ref-type="fig"}A). We found that NAC treatment alone had no significant effect on the burden of *p53*^*∗/WT*^-induced mutant basal cells in EE ([Figures 6](#fig6){ref-type="fig"}B and 6C). Remarkably, however, rather than simply rescuing the effect of LDIR on mutant cell expansion, NAC treatment resulted in a substantial decrease in the proportion of *p53*^*∗/WT*^ mutant basal cells in EE ([Figure 6](#fig6){ref-type="fig"}D). This change was accompanied by a significant shift from basal to differentiated cells and an increase in the proportion of floating mutant clones with no remaining basal cells, arguing that mutant clones were being lost by differentiation and shedding ([Figures 6](#fig6){ref-type="fig"}E and 6F).Figure 6The *p53*^*∗/WT*^ Mutant Population Decreases after Combined Antioxidant Treatment and Several LDIR Exposures(A) Experimental protocol. Mice were given the oral antioxidant NAC 7 days after the *p53*^*∗/WT*^ allele was induced (green arrow) and kept throughout the experiment. Animals were irradiated with five doses of 50 mGy LDIR over 30 days, commenced with a minimal separation of 3 days between each dose. EdU was injected 1 h prior the last irradiation (red arrow).(B) Percentage of *p53*^*∗/WT*^ basal cells in mice treated with or without NAC and non-irradiated. Points show mean values from individual mice. n.s., p \> 0.05 by unpaired t test; n = 10 mice (−NAC) and n = 6 mice (+NAC).(C) Top-down views of confocal z stacks of typical EE whole mounts showing *p53*^∗/*WT*^ clones (green) under --NAC and +NAC treatments. Basal layer cells are shown. DAPI is shown in blue. Scale bars, 28 μm.(D) Percentage of *p53*^*∗/WT*^ basal cells in mice exposed to 50 mGy × 5 and treated with NAC or left untreated. Points show mean values from individual mice. ^∗∗∗^p \< 0.001 (t test), n = 6 mice per condition.(E) Heatmaps showing clone sizes in 0 and 50 mGy × 5 irradiated mice treated with NAC. Black dots and dashed lines indicate geometric median clone size.(F) Frequency change of NAC-treated versus non-treated mice exposed to 50 mGy × 5 LDIR. ^∗∗∗∗^p \< 0.0001 (Peacock's test), n = 300 clones per condition.(G) Top-down views of confocal z stacks of typical EE whole mounts showing *p53*^∗/WT^ clones (green), Ki67^+^ basal cells (white), and EdU^+^ basal cells (red) after 50 mGy × 5 LDIR without or with NAC treatment. Basal layer cells are shown (DAPI, blue). Scale bars, 40 μm.(H and I) Comparison of *p53*^*∗/WT*^ clones with adjacent *p53*^*WT/WT*^ EE in the same irradiated animal treated with NAC. Shown are the percentages of EdU^+^ suprabasal cells (H) and Ki67^+^ basal cells (I). Points show mean values from 3 mice, and lines link the same animal. ^∗∗^p \< 0.01, ^∗^p \< 0.05 (paired t test).(J) Summary. 30 days after 5 doses of 50 mGy, *p53*^∗/*WT*^ clones have expanded through the tissue, replenishing empty space left by *p53*^*WT*/WT^ clones when they differentiate. When animals are co-treated with the same 5 doses of 50 mGy plus NAC, *p53*^∗/*WT*^ clones are displaced from the tissue by *p53*^*WT*/*WT*^ clones.See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S6](#mmc1){ref-type="supplementary-material"} and [Tables S2](#mmc1){ref-type="supplementary-material"} and [S4](#mmc3){ref-type="supplementary-material"}.

To gain more insight into the cellular mechanisms of p53 mutant clone loss in animals treated with NAC and LDIR, we used short-term lineage tracing with EdU, allowing us to track the fate of proliferating mutant and wild-type cells in the same mouse. We found that, 48 h after EdU labeling, the proportion of differentiated EdU-positive cells was significantly higher in mutant than in wild-type cells ([Figures 6](#fig6){ref-type="fig"}G and 6H). Correspondingly, we found that the proportion of basal cells expressing the proliferation-associated antigen Ki67 was reduced in mutant compared with wild-type cells ([Figure 6](#fig6){ref-type="fig"}I). These findings were consistent independent of whether EdU labeling was performed after 2 or 5 doses of LDIR ([Figures S6](#mmc1){ref-type="supplementary-material"}D--S6G). We conclude that the loss of competitive fitness of mutant relative to wild-type cells is due to a shift in the outcome of cell division. *p53*^*∗/WT*^ mutant basal cells are less likely to produce proliferating daughters than wild-type cells, resulting in depletion of p53 mutant clones, allowing wild-type cells to recolonize areas of the basal layer previously occupied by *p53*^*∗/WT*^ clones ([Figure 6](#fig6){ref-type="fig"}J).

Discussion {#sec3}
==========

These results reveal that external factors can modify clonal selection in normal tissues by altering the competitive balance between mutant and wild-type cells. Redox stress induced by LDIR acts as selective pressure by driving wild-type cells to differentiate. However, high-level expression of endogenous antioxidants in *p53* mutant basal cells protects them against radiation-induced differentiation. Loss of wild-type cells from the basal layer facilitates the expansion of mutant clones. Treating animals with an exogenous antioxidant, NAC, protects wild-type cells from LDIR-induced differentiation and turns the tables on mutant clones, which have an increased likelihood of loss by shedding under these conditions.

It is notable that antioxidant treatment alone has no effect on p53 mutant clones in EE. Indeed, in humans, antioxidants have not only been proven to be ineffective in human cancer prevention studies but may increase all-cause mortality ([@bib7]); the combination of antioxidant treatment followed by a pro-oxidant challenge might remodel the normal tissue mutational landscape in a beneficial manner. Antioxidants may also mitigate the effects of planned LDIR exposure on *p53* mutant clones. More generally, in light of the observation that some aging tissues are patchworks of mutant clones, our results reveal that external interventions that raise the competitive fitness of wild-type cells above that of mutants may be an attractive option for depleting tissues of potentially harmful mutations.

Finally, our results highlight the potential effect of repeated exposure to small doses of ionizing radiation such as what may be encountered by patients having frequent CT scans. Such low doses may have a negligible mutagenic effect but, by altering the dynamics of normal tissues with a high burden of mutant clones, may modulate the risks of neoplastic and other diseases.

STAR★Methods {#sec5}
============

Key Resources Table {#sec5.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Caspase 3AbcamCat\# ab2302; RRID: AB_302962Histone H2A.X (phospho Ser139)MilliporeCat\# 05-636; RRID:[AB_309864](nif-antibody:AB_309864){#intref0010}53BP1NovusbioCat\# NB100-304; RRID:[AB_10003037](nif-antibody:AB_10003037){#intref0015}GFP/YFPThermo Fisher ScientificCat\# A10262; RRID:[AB_2534023](nif-antibody:AB_2534023){#intref0020}Cytokeratin 4AbcamCat\# ab9004; RRID:[AB_306932](nif-antibody:AB_306932){#intref0025}alpha-TubulinCell signalingCat\# 2125; RRID:[AB_2619646](nif-antibody:AB_2619646){#intref0030}Ki67AbcamCat\# ab15580; RRID:[AB_443209](nif-antibody:AB_443209){#intref0035}Histone H3 (phospho Ser10)AbcamCat\# ab14955; RRID:[AB_443110](nif-antibody:AB_443110){#intref0040}Nrf2 (phospho Ser40)AbcamCat\# ab76026; RRID:[AB_1524049](nif-antibody:AB_1524049){#intref0045}Chk1Santa CruzCat\# sc-8408; RRID:[AB_627257](nif-antibody:AB_627257){#intref0050}Chk1 (phosphor Ser345)Cell SignalingCat\# 2348; RRID:[AB_331212](nif-antibody:AB_331212){#intref0055}Chk2Cell SignalingCat\# 2662; RRID:[AB_2080793](nif-antibody:AB_2080793){#intref0060}Chk2 (phospho Thr68)Cell SignalingCat\# 2661; RRID:[AB_331479](nif-antibody:AB_331479){#intref0065}p53Vector LaboratoriesCat\# VP-P956; RRID: AB_2335917p53 (phospho Ser15)Cell signalingCat\# 9284; RRID: AB_331464p38 MAPKCell signalingCat\# 9212; RRID:[AB_330713](nif-antibody:AB_330713){#intref0070}p38 MAPK (phosphor Thr180/Tyr182)Cell signalingCat\# 9215; RRID:[AB_331762](nif-antibody:AB_331762){#intref0075}Alexa Fluor 647 Wheat Germ AgglutininInvitrogenCat\# W32466Alexa Fluor 647 anti-human/mouse CD49fBioLegendCat\# 313610; RRID:AB_493637Alexa Fluor 488 Donkey Anti-ChickenJackson ImmunoResearchCat\# 703-545-155; RRID:[AB_2340375](nif-antibody:AB_2340375){#intref0080}Alexa Fluor 555 Donkey Anti-MouseThermo Fisher ScientificCat\# A-31570; RRID:[AB_2536180](nif-antibody:AB_2536180){#intref0085}Alexa Fluor 555 Donkey Anti-RabittThermo Fisher ScientificCat\# A-31572; RRID:[AB_162543](nif-antibody:AB_162543){#intref0090}Alexa Fluor 647 Donkey Anti-RabittThermo Fisher ScientificCat\# A-31573; RRID:[AB_2536183](nif-antibody:AB_2536183){#intref0095}Alexa Fluor 488 Donkey Anti-MouseThermo Fisher ScientificCat\# A-21202; RRID:[AB_141607](nif-antibody:AB_141607){#intref0100}**Bacterial and Virus Strains**Adeno-CMV-iCreVector LaboratoriesCat\# 1045**Chemicals, Peptides, and Recombinant Proteins**β-NapthoflavoneMP BiomedicalsCat\# 156738TamoxifenSigma AldrichCat\# N3633Fish Skin gelatinSigma AldrichCat\# G7765Bovine Serum AlbuminMerk MilliporeCat\# 126575Donkey serumSigma AldrichCat\# D9633N-EthylmaleimideSigma AldrichCat\# 04259-5GSodium HidroxideVWRCat\# 191373MN-Acetyl L-CysteineLKT LabsCat\# A0918Hydrogen Peroxide 30%Merk MilliporeCat\# 107298DMEMThermo Fisher ScientificCat\# 11971025DMEM/F-12Thermo Fisher ScientificCat\# 31330HBSSGIBCOCat\#14175-053InsulinSigma AldrichCat\# I5500AdenineSigma AldrichCat\# A3159HydrocortisoneCalbiochemCat\# 386698Cholera toxinSigma-AldrichCat\# C8052Epidermal growth factorPeproTechCat\# 100-15Apo-TransferrineSigma-AldrichCat\# T2036Fetal calf serumPAA LaboratoriesCat\# A15-041Penicillin-StreptomycinSigma AldrichCat\# P0781Amphotericin BSigma AldrichCat\# A2942Protease and Phosphatase inhibitorThermo Fisher ScientificCat\# 7841540, 6-diamidino-2-phenylindole (DAPI)Sigma AldrichCat\# D9542PolybreneSigma AldrichCat\# H9268Trypsin/EDTASigma AldrichCat\# T4174RIPA bufferThermo Fisher ScientificCat\# 89900Pierce BCA Protein Assay KitThermo Fisher ScientificCat\# 23227**Critical Commercial Assays**Click-iT EdU imagingLife technologiesCat\# C10086RNeasy Mini kitQIAGENCat\# 74106Lipofectamine 2000Thermo FisherCat\# 11668-019QuickSTART Bradford Dye reagentsBioRADCat\# 500-0202Maxi Prep Endotoxin free kitQIAGENCat\# 12362Wes SimpleProteinSimpleCat\# P/N 031-108QIAamp DNA Micro KitQIAGENCat\# 56304**Deposited Data**RNaseq data: p53^wt/wt^This paperWt_Ctrl_1A; ENA: ERS1432686RNaseq data: p53^wt/wt^This paperWt_Ctrl_1B; ENA: ERS1432689RNaseq data: p53^wt/wt^This paperWt_Ctrl_1C; ENA: ERS1432688RNaseq data: p53^wt/wt^This paperWt_Ctrl_24A; ENA: ERS1432703RNaseq data: p53^wt/wt^This paperWt_Ctrl_24B; ENA: ERS1432704RNaseq data: p53^wt/wt^This paperWt_Ctrl_24C; ENA: ERS1432705RNaseq data: p53^wt/wt^This paperWt_50mGy_1A; ENA: ERS1432693RNaseq data: p53^wt/wt^This paperWt_50mGy_1B; ENA: ERS1432694RNaseq data: p53^wt/wt^This paperWt_50mGy_1C; ENA: ERS1432690RNaseq data: p53^wt/wt^This paperWt_50mGy_24A; ENA: ERS1432691RNaseq data: p53^wt/wt^This paperWt_50mGy_24B; ENA: ERS1432692RNaseq data: p53^wt/wt^This paperWt_50mGy_24C; ENA: ERS1432695RNaseq data: p53^∗/wt^This paperp53_mut_Ctrl_1A; ENA: ERS1432636RNaseq data: p53^∗/wt^This paperp53_mut_Ctrl_1B; ENA: ERS1432637RNaseq data: p53^∗/wt^This paperp53_mut_Ctrl_1C; ENA: ERS1432634RNaseq data: p53^∗/wt^This paperp53_mut_Ctrl_24A; ENA: ERS1432638RNaseq data: p53^∗/wt^This paperp53_mut_Ctrl_24B; ENA: ERS1432635RNaseq data: p53^∗/wt^This paperp53_mut_Ctrl_24C; ENA: ERS1432639RNaseq data: p53^∗/wt^This paperp53_mut_50mGy_1A; ENA: ERS1432640RNaseq data: p53^∗/wt^This paperp53_mut_50mGy_1B; ENA: ERS1432641RNaseq data: p53^∗/wt^This paperp53_mut_50mGy_1C; ENA: ERS1432642RNaseq data: p53^∗/wt^This paperp53_mut_50mGy_24A; ENA: ERS1432643RNaseq data: p53^∗/wt^This paperp53_mut_50mGy_24B; ENA: ERS1432647RNaseq data: p53^∗/wt^This paperp53_mut_50mGy_24C; ENA: ERS1432644RNaseq data: Nrf2^−/−^This paperNRF2KO_Ctrl_1A; ENA: ERS1432706RNaseq data: Nrf2^−/−^This paperNRF2KO_Ctrl_1B; ENA: ERS1432707RNaseq data: Nrf2^−/−^This paperNRF2KO_Ctrl_1C; ENA: ERS1432708RNaseq data: Nrf2^−/−^This paperNRF2KO_Ctrl_24A; ENA: ERS1432709RNaseq data: Nrf2^−/−^This paperNRF2KO_Ctrl_24B; ENA: ERS1432710RNaseq data: Nrf2^−/−^This paperNRF2KO_Ctrl_24C; ENA: ERS1432711RNaseq data: Nrf2^−/−^This paperNRF2KO_50mGy_1A; ENA: ERS1432712RNaseq data: Nrf2^−/−^This paperNRF2KO_50mGy_1B; ENA: ERS1432713RNaseq data: Nrf2^−/−^This paperNRF2KO_50mGy_1C; ENA: ERS1432714RNaseq data: Nrf2^−/−^This paperNRF2KO_50mGy_24A; ENA: ERS1432715RNaseq data: Nrf2^−/−^This paperNRF2KO_50mGy_24B; ENA: ERS1432716RNaseq data: Nrf2^−/−^This paperNRF2KO_50mGy_24C; ENA: ERS1432717**Experimental Models: Cell Lines**Human derived amphotrophic phoenix cellATCCATCC CRL-3213**Experimental Models: Organisms/Strains**Mouse: C57BL/6JThe Jackson LaboratoryJAX: 000664Mouse: *Nfe2l2*^*−/−*^[@bib9]JAX: 017009Mouse: *Ahcre*^*ERT*^*Trp53*^*flR245W/wt*^[@bib30]N/AMouse: *Ahcre*^*ERT*^*Rosa26*^*flYFP/wt*^[@bib10]N/A**Recombinant DNA**pLPCX/mito-roGFP2-Grx1Addgene\#64977**Software and Algorithms**LAS XLeicaN/AVolocity 6 and 6.3Perkin ElmerN/AImarisBitplaneN/AGraphPadPrism 6N/ASTAR 2.5.3a[@bib12]N/AHTSeq framework version 0.6.1p1[@bib4]N/AR package: DESeq2[@bib24]<https://bioconductor.org/packages/release/bioc/html/DESeq2.html>R package: pheatmap<https://cran.r-project.org/web/packages/pheatmap/index.html>R package: RColorBrewer<https://cran.r-project.org/web/packages/RColorBrewer/index.html>R package: clusterProfiler[@bib40]<https://bioconductor.org/packages/release/bioc/html/clusterProfiler.html>R package: org.Mm.eg.db<https://bioconductor.org/packages/release/data/annotation/html/org.Mm.eg.db.html>MATLAB R2016bMathWorksN/AJupyter & Spyder 3.1 (Python 3)Python Software FoundationN/A**Other**Leica TCS SP8LeicaN/ARS225 X-Ray irradiatorXstrahlRS225Caesium source irradiatorGamma-Service medical GmbHGSR D1UNIDOS E universal dosimeterPTWN/AUV-irradiator CL-508MUvitecN/A

Lead Contact and Materials Availability {#sec5.2}
---------------------------------------

Requests for reagent and resource sharing should be addressed to the Lead Contact, Philip H. Jones (<pj3@sanger.ac.uk>) who will fulfil requests.

Experimental Model and Subject Details {#sec5.3}
--------------------------------------

### Mice strains and induction of allele {#sec5.3.1}

All experiments were approved by the local ethical review committees at the UK Medical Research Council (MRC), University of Cambridge and Wellcome Sanger Institute, and conducted according to Home Office project licenses PPL70/7543 and PF4639B40 and Home Office personal license P14FED054. *AhCreERT-R26*^*flEYFP/wt*^ experimental mice express YFP from the Rosa 26 locus following *cre* induction. In these mice, transcription of a *cre* mutant estrogen receptor fusion protein (*cre*^*ERT*^) is induced by β-naphthoflavone. Tamoxifen is also required for CRE*-*ERT protein to gain access to the nucleus. *p53*^*eGFP-R245W/wt*^ mice express the R245W mutant version of *p53* and can be detected by GFP expression following *cre* induction ([@bib30]). Prior to *cre*-mediated recombination these animals (*p53*^*∗/wt*^) express TRP53 protein from two wild-type alleles. Once the wild-type *Trp53* genomic region is deleted by *cre* both the *Trp53* mutant carrying the R245W mutation and the *eGFP* reporter are transcribed. Animals were induced between 10 and 16 weeks of age. *Nrf2*^*−/−*^ (*Nfe2l2*^*tm1Ywk*^) animals were purchased from the Jackson Laboratory, USA. *C57BL/6J* wild-type mice were also used as indicated. All strains were maintained in a *C57BL/6* background. Where indicated, mice were treated with the antioxidant N-acetyl-Cysteine, NAC (Life Technologies) at 2% (w/v) in drinking water for the duration of the experiment. On average mice consumed ca.1 g/kg NAC per day. Experiments were carried out with male and female animals and no gender specific differences were observed.

### Irradiation {#sec5.3.2}

*In vivo* total body irradiation (TBI) was performed using a cesium gamma irradiator (Central of Biomedical Services, University of Cambridge). 40 kg lead plates were used to attenuate the dose rate from 1 Gy/min to 16 mGy/min. Gamma dosimetry was performed by RSP Service Ltd, UK and by Personal Dosimetry Service, Public Health England Centre for Radiation, UK, using thermoluminescent dosimeters to confirm that the delivered doses were accurate. *In vitro* irradiation was performed using an Xstrahl RS225 X-Ray irradiator (Xstrahl, Ltd. UK) with copper and lead filters at 195 KV, 10 mA and 37°C. Xstral dosimetry was performed using UNIDOS E universal dosimeter (PTW, Germany) with an ion chamber detector, corrected for air pressure and temperature values for each experiment.

### Lineage tracing {#sec5.3.3}

Low frequency expression of YFP and GFP in the mouse esophagus was achieved by inducing animals aged 10--16 weeks with an intraperitoneal dose of 80 mg/kg β-naphthoflavone and 0.25 mg tamoxifen (YFP) and 8 mg/kg β-naphthoflavone and 0.1 mg tamoxifen (GFP). Following induction, between three and eight mice per time point were culled and the esophagus collected. Time points analyzed include 24, 48 hours and 1 month after the first irradiation. Total number of clones quantified for each figure can be found in [Table S3](#mmc2){ref-type="supplementary-material"}. Clones were imaged after immunostaining wholemounts of EE, described below, on an SP8 Leica confocal microscope. The numbers of basal and suprabasal cells in each clone were counted under live acquisition mode. Representative images of clones were produced by rendering confocal z stacks with the following settings: 40X objective with 1.5x digital zoom, optimal pinhole, speed 400 Hz, line average 3, optimal step size, and resolution of 1024 × 1024. Images were reconstructed from optical sections using Volocity 6 software (PerkinElmer) and Imaris (Bitplane). Normalized, clone-size distributions were built for each experimental condition and time point from the observed relative frequencies *f*~*m,n*~ of clones of a certain size, containing *m* basal and *n* suprabasal cells, resulting in two-dimensional histograms (displayed as heatmaps). A 2D histogram of the residuals or differences observed between conditions in the relative frequencies of each particular clone size (i.e., each cell on the grid) was generated when appropriate.

### Primary keratinocyte 3D culture {#sec5.3.4}

After removing muscle layer with fine forceps, small pieces of esophageal explants (2 mm^2^) were placed onto a transparent ThinCert™ insert (Greiner Bio-One) with the epithelium facing upward and the submucosa stretched over the membrane, dried for 30 minutes at 37°C to ensure attachment and cultured in complete FAD medium (50:50) 4.5 g/L D-Glucose, Pyruvate, L-Glutamine D-MEM (Invitrogen 11971-025): D-MEM/F12 (Invitrogen 31330-038), supplemented with 5 μg/ml insulin (Sigma-Aldrich I5500), 1.8 × 10^−4^ M adenine (Sigma-Aldrich A3159), 0.5 μg/ml hydrocortisone (Calbiochem 386698), 1 x10^−10^ M cholera toxin (Sigma-Aldrich C8052), 10 ng/ml Epidermal Growth Factor (EGF, PeproTech EC Ltd 100-15), 5% fetal calf serum (PAA Laboratories A15-041), 5% Penicillin-Streptomycin (Sigma Aldrich, P0781), 1% Amphotericin B (Sigma Aldrich, A2942) and 5 μg/ml Apo-Transferrine (Sigma-Aldrich T2036). Explants were removed after 7 days once keratinocytes have covered half of the membrane. Media was changed every three days. Cholera toxin, epidermal growth factor and hydrocortisone were removed from the medium two weeks before starting experiments. N-Acetyl L-Cysteine (NAC, LKT Labs, A0918) was dissolved in deionized water (1 M stock solution) adjusted to pH 7.2 and then diluted in cell culture medium to 1 mM final concentration.

### Adenoviral infections {#sec5.3.5}

To establish mouse primary keratinocyte 3D cultures from *p53*^*GFP-R245w/*+^ mice, cells were infected with *Cre*-expressing adenovirus (Ad-CMV-iCre, Vectorbiolabs, \#1045 UK). Briefly, cells were incubated with adenovirus-containing medium supplemented with Polybrene (Sigma Aldrich, \# H9268) (4 μg/ml) for 24 hours at 37°C, 5% CO~2~. Cells were washed and fresh medium was added. Infection rates were \> 95%.

### Immunofluorescence {#sec5.3.6}

For wholemount staining, EE from the middle two thirds of the esophagus was prepared by opening longitudinally, removing the muscle layer and incubating for 1 hour and 30 minutes in 20 mM EDTA-PBS at 37°C. The epithelium was then carefully peeled away from underlying tissue with fine forceps, stretched and fixed in 4% paraformaldehyde in PBS for 30 min. For staining, wholemounts were blocked for 1 hour in blocking buffer (0.5% bovine serum albumin, 0.25% fish skin gelatine, 0.5% Triton X-100 and 10% donkey serum) in PHEM buffer (60 mM PIPES, 25 mM HEPES, 10 mM EGTA, and 4 mM MgSO~4~·7H~2~0). Primary and secondary antibodies were incubated overnight using blocking buffer, followed by several washes over 2-3 hours with 0.2% Tween-20 in PHEM buffer. A final overnight incubation with 1 μg/ml DAPI in PHEM buffer was used to stain cell nuclei. For staining conventional tissue sections, optimal cutting temperature compound (OCT) embedded esophageal cryosections of 10-14 μm thickness were fixed with 2% paraformaldehyde for 5 min, blocked in blocking buffer and stained with the respective primary and secondary antibodies for 1 hour at room temperature. Samples were washed with PHEM buffer between incubations. EdU incorporation was detected with Click-iT chemistry kit according to the manufacturer's instructions (Invitrogen) using 647 or 555 Alexa Fluor azides. Confocal images were acquired on a Leica TCS SP8 confocal microscope (objectives × 20 and × 40; optimal pinhole; speed 400 Hz; line average 3; resolution 1024 × 1024) and reconstructed using Volocity 6 image processing software (PerkinElmer) and Imaris (Bitplane). Antibodies used are listed in Table S1.

### EdU lineage tracing {#sec5.3.7}

For *in vivo* lineage tracing, 10 μg of EdU in PBS was administered by intraperitoneal injection, 1 hour before the last irradiation. Tissues were collected, 2, 24 and 48 hours after injection. EdU-positive basal and suprabasal cells were quantified from a minimum of 10 z stack images (objective × 40; optimal pinhole; speed 400 Hz; line average 3; resolution 1024 × 1024, zoom × 1.5) from wholemounts or 3D cultures. For *in vitro* lineage tracing, 10 μM EdU was added to the culture and incubated for 1 hour at 37°C and 5% CO~2~. After EdU incubation, media was changed and cells were irradiated with 50 mGy. Samples were collected at different time points after irradiation.

### Basal cell density {#sec5.3.8}

Relative cell density was calculated in 0 mGy and 50 mGy irradiated mice at different time points by imaging the basal layer from EE wholemounts or 3D cultures and quantifying the number of DAPI^+^ basal cells per field in 5-10 random images per animal.

### RNA isolation and RNA sequencing {#sec5.3.9}

Total RNA was extracted from 3D cultures of mouse primary keratinocytes using RNeasy Micro Kit (QIAGEN, UK), following the manufacturer's recommendations, including on column DNase digestion. Briefly, cells were washed with cold Hank's Balanced Salt Solution-HBSS (GIBCO, UK) and then lysis buffer was added directly to the insert. The integrity of total RNA was determined by Qubit RNA Assay Kit (Invitrogen, UK). For RNA-seq, libraries were prepared in an automated fashion using an Agilent Bravo robot with a KAPA Standard mRNA-Seq Kit (KAPA BIOSYSTEMS). In house adaptors were ligated to 100-300 bp fragments of dsDNA. All the samples were then subjected to 10 PCR cycles using sanger_168 tag set of primers and paired-end sequencing was performed on Illumina HiSeq 2500 with 75 bp read length. Reads were mapped using STAR 2.5.3a, the alignment files were sorted and duplicate-marked using Biobambam2 2.0.54, and the read summarization performed by the htseq-count script from version 0.6.1p1 of the HTSeq framework ([@bib4], [@bib12]). Differential gene expression was analyzed using the DESeq2 R package ([@bib24]), and the downstream pathway analysis and visualization using R (<https://www.R-project.org/>) and the packages Pheatmap (<https://cran.r-project.org/web/packages/pheatmap/index.html>), RColorBrewer (<https://cran.r-project.org/web/packages/RColorBrewer/index.html>), clusterProfiler ([@bib40]) and org.Mm.eg.db (<http://bioconductor.org/packages/release/data/annotation/html/org.Mm.eg.db.html>). Differentially-expressed genes are hits reported by DESeq2 with adjusted p value (padj) of less than 0.05. Heatmaps were generated from the ratio of TPM values of the treated sample over the average of the respective control samples.

### Immune capillary electrophoresis {#sec5.3.10}

For protein phosphorylation analysis, 3D cultures were irradiated with 0 mGy, 50 mGy or 2 Gy and incubated for 1 or 6 hours at 37°C 5% CO~2~. Cultures were lysed in ice-cold RIPA buffer (Thermo Scientific, UK) containing protease and phosphatase inhibitors and incubated on ice for 30 min. Cell lysate was passed through a 25G needle at least 10 times to increase nuclear lysis and centrifuged at 14000 g for 20 min at 4°C. The supernatant was collected for analysis. Total protein quantification was performed using Pierce BCA Protein Assay Kit (Thermo Scientific, UK). Immune capillary electrophoresis was performed using Wes Simple™ (ProteinSimple, USA) following manufacturer's instructions.

### Mitochondrial redox measurements {#sec5.3.11}

A genetically encoded redox-sensitive biosensor fluorescent protein (roGFP2) fused to redox-active protein (Grx1) and with an N-terminal mitochondrial targeting sequence (mito-roGFP2-Grx1), was used for the measurement of glutathione redox potential. Primary mouse keratinocytes (PMOKs) expressing mito-roGFP2-Grx1 were established by retroviral transduction. Briefly, Phoenix-AMPHO cells were transfected with pLPCX/mito-roGFP2-Grx1 using lipofectamine (Life Technologies) following the manufacturer's protocol. 8 hours post- transfection, cells were washed twice with HBSS and fresh medium was added. 48 hours after transfection the supernatant was collected and passed through a 0.44 μm filter. 24 hours before infection PMOKs were seeded at 10^6^ cells per insert in a six-well plate (ThinCert™ insert, Greiner Bio-One). PMOKs were incubated with the virus-containing supernatant supplemented with Polybrene (4 μg/ml) for 24 hours at 37°C 5% CO~2~. Cells were then grown in medium containing puromycin (0.5 μg/ml) for several days before starting each experiment. PMOKs expressing mito-roGFP2-Grx1 were irradiated with 0 mGy or 50 mGy and incubated for 5, 30 or 60 minutes at 37°C, 5% CO~2~. Cells were then treated with 20 mM N-ethylmaleimide (NEM) for 5 min at room temperature prior to 4% PFA fixation for 10 minutes at room temperature. Cells were washed in HBSS twice and incubated with wheat germ agglutinin (WGA) to stain the cell membrane. Confocal 3D images were acquired on a Leica TCS SP8 confocal microscope ( × 40 objective; optimal pinhole; speed 400 Hz; line average 1; resolution, 1024 × 1024, optimal step size) using 405nm and 488nm laser lines for excitation and 500-540nm filter for emission collection. 3D images were processed using Imaris (Bitplane) or ImageJ to identify each mitochondria and to calculate 405/488 ratio. Number of mitochondria analyzed for each condition is shown in [Table S2](#mmc1){ref-type="supplementary-material"}. Background subtraction for each channel was performed. For pseudocolor display, the ratio was coded on a spectral color scale ranging from blue (fully reduced) to white (fully oxidized), with limits set by the *in situ* calibration. Calibration was done using 20 mM DTT and 100 μM H~2~O~2~ treated samples to drive roGFP2 to their fully reduced and fully oxidized forms, respectively.

Quantification and Statistical Analysis {#sec5.4}
---------------------------------------

Data are expressed as median values ± SEM unless otherwise indicated. Differences between groups were assessed by 2 tailed unpaired t test or Anova for normally distributed data or 2 tailed Mann-Whitney U test for skewed data, using GraphPad Prism software. For the mitochondrial 405/488 ratios, one-tailed Mann-Whitney U test was used for pairwise comparisons (α = 0.05). For paired comparisons of clonal behavior across conditions, Peacock's test was used, a two-dimensional extension of Kolmogorov-Smirnov test (implemented as kstest_2s_2d function for MATLAB) ([@bib31]). No statistical method was used to predetermine sample size. The experiments were not randomized. The investigators were not blinded to allocation during experiments and outcome assessment.
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